Norinchukin Bank The Has $2.94 Million Stake in CME Group Inc (CME)

Norinchukin Bank The grew its stake in CME Group Inc (NASDAQ:CME) by 10.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 20,160 shares of the financial services provider’s stock after purchasing an additional 1,932 shares during the period. Norinchukin Bank The’s holdings in CME Group were worth $2,944,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. Valeo Financial Advisors LLC bought a new stake in shares of CME Group in the 3rd quarter valued at approximately $124,000. Bank of Nova Scotia Trust Co. acquired a new position in shares of CME Group in the 3rd quarter worth approximately $165,000. SeaCrest Wealth Management LLC acquired a new position in shares of CME Group in the 4th quarter worth approximately $203,000. Wesbanco Bank Inc. acquired a new position in shares of CME Group in the 4th quarter worth approximately $205,000. Finally, Dempze Nancy E acquired a new position in shares of CME Group in the 4th quarter worth approximately $205,000. Institutional investors own 82.63% of the company’s stock.

CME Group Inc (CME) opened at $163.35 on Wednesday. CME Group Inc has a 1-year low of $114.82 and a 1-year high of $165.35. The company has a current ratio of 1.03, a quick ratio of 1.05 and a debt-to-equity ratio of 0.10. The stock has a market capitalization of $55,065.49, a price-to-earnings ratio of 34.11, a price-to-earnings-growth ratio of 2.10 and a beta of 0.64.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.10 by $0.02. CME Group had a return on equity of 7.68% and a net margin of 111.49%. The firm had revenue of $900.00 million for the quarter, compared to the consensus estimate of $886.85 million. During the same quarter in the prior year, the business earned $1.14 EPS. The business’s revenue for the quarter was down 1.4% compared to the same quarter last year. equities analysts expect that CME Group Inc will post 6.32 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 26th. Shareholders of record on Friday, March 9th will be issued a dividend of $0.70 per share. This is an increase from CME Group’s previous quarterly dividend of $0.66. The ex-dividend date is Thursday, March 8th. This represents a $2.80 annualized dividend and a yield of 1.71%. CME Group’s dividend payout ratio is currently 22.11%.

Several research analysts have recently commented on the company. BidaskClub raised CME Group from a “buy” rating to a “strong-buy” rating in a report on Saturday, February 10th. Goldman Sachs Group raised CME Group from a “neutral” rating to a “buy” rating and set a $180.00 target price on the stock in a report on Wednesday, February 7th. Bank of America boosted their target price on CME Group from $173.00 to $175.00 and gave the stock a “buy” rating in a report on Friday, February 2nd. Barclays boosted their target price on CME Group from $170.00 to $175.00 and gave the stock an “overweight” rating in a report on Friday, February 2nd. Finally, Sandler O’Neill reissued a “buy” rating and issued a $175.00 target price on shares of CME Group in a report on Friday, February 2nd. Three analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. CME Group has a consensus rating of “Buy” and a consensus price target of $157.00.

In other news, insider Kimberly S. Taylor sold 8,125 shares of the stock in a transaction on Thursday, November 30th. The stock was sold at an average price of $150.00, for a total value of $1,218,750.00. Following the transaction, the insider now owns 120,590 shares of the company’s stock, valued at approximately $18,088,500. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Julie Holzrichter sold 12,920 shares of the stock in a transaction on Tuesday, November 28th. The shares were sold at an average price of $144.08, for a total value of $1,861,513.60. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 64,728 shares of company stock worth $9,755,257. Company insiders own 0.57% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Norinchukin Bank The Has $2.94 Million Stake in CME Group Inc (CME)” was originally published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The original version of this piece can be accessed at https://stocknewstimes.com/2018/02/21/norinchukin-bank-the-has-2-94-million-stake-in-cme-group-inc-cme.html.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply